Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 27


Antibody escape kinetics of equine infectious anemia virus infection of horses.

Schwartz EJ, Nanda S, Mealey RH.

J Virol. 2015 Jul;89(13):6945-51. doi: 10.1128/JVI.00137-15. Epub 2015 Apr 15.


Theileria equi isolates vary in susceptibility to imidocarb dipropionate but demonstrate uniform in vitro susceptibility to a bumped kinase inhibitor.

Hines SA, Ramsay JD, Kappmeyer LS, Lau AO, Ojo KK, Van Voorhis WC, Knowles DP, Mealey RH.

Parasit Vectors. 2015 Jan 20;8:33. doi: 10.1186/s13071-014-0611-6.


Lymphocytes and macrophages are infected by Theileria equi, but T cells and B cells are not required to establish infection in vivo.

Ramsay JD, Ueti MW, Johnson WC, Scoles GA, Knowles DP, Mealey RH.

PLoS One. 2013 Oct 7;8(10):e76996. doi: 10.1371/journal.pone.0076996. eCollection 2013.


Serum antibodies from a subset of horses positive for Babesia caballi by competitive enzyme-linked immunosorbent assay demonstrate a protein recognition pattern that is not consistent with infection.

Awinda PO, Mealey RH, Williams LB, Conrad PA, Packham AE, Reif KE, Grause JF, Pelzel-McCluskey AM, Chung C, Bastos RG, Kappmeyer LS, Howe DK, Ness SL, Knowles DP, Ueti MW.

Clin Vaccine Immunol. 2013 Nov;20(11):1752-7. doi: 10.1128/CVI.00479-13. Epub 2013 Sep 18.


Comparative genomic analysis and phylogenetic position of Theileria equi.

Kappmeyer LS, Thiagarajan M, Herndon DR, Ramsay JD, Caler E, Djikeng A, Gillespie JJ, Lau AO, Roalson EH, Silva JC, Silva MG, Suarez CE, Ueti MW, Nene VM, Mealey RH, Knowles DP, Brayton KA.

BMC Genomics. 2012 Nov 9;13:603. doi: 10.1186/1471-2164-13-603.


Re-emergence of the apicomplexan Theileria equi in the United States: elimination of persistent infection and transmission risk.

Ueti MW, Mealey RH, Kappmeyer LS, White SN, Kumpula-McWhirter N, Pelzel AM, Grause JF, Bunn TO, Schwartz A, Traub-Dargatz JL, Hendrickson A, Espy B, Guthrie AJ, Fowler WK, Knowles DP.

PLoS One. 2012;7(9):e44713. doi: 10.1371/journal.pone.0044713. Epub 2012 Sep 6.


Protective effects of passively transferred merozoite-specific antibodies against Theileria equi in horses with severe combined immunodeficiency.

Mealey RH, Kappmeyer LS, Ueti MW, Wagner B, Knowles DP.

Clin Vaccine Immunol. 2012 Jan;19(1):100-4. doi: 10.1128/CVI.05301-11. Epub 2011 Oct 28.


Decreased infectivity of a neutralization-resistant equine infectious anemia virus variant can be overcome by efficient cell-to-cell spread.

Wu W, Blythe DC, Loyd H, Mealey RH, Tallmadge RL, Dorman KS, Carpenter S.

J Virol. 2011 Oct;85(19):10421-4. doi: 10.1128/JVI.05349-11. Epub 2011 Jul 13.


Protective effects of broadly neutralizing immunoglobulin against homologous and heterologous equine infectious anemia virus infection in horses with severe combined immunodeficiency.

Taylor SD, Leib SR, Wu W, Nelson R, Carpenter S, Mealey RH.

J Virol. 2011 Jul;85(13):6814-8. doi: 10.1128/JVI.00077-11. Epub 2011 May 4.


Early development of cytotoxic T lymphocytes in neonatal foals following oral inoculation with Rhodococcus equi.

Harris SP, Hines MT, Mealey RH, Alperin DC, Hines SA.

Vet Immunol Immunopathol. 2011 Jun 15;141(3-4):312-6. doi: 10.1016/j.vetimm.2011.03.015. Epub 2011 Mar 21.


Development of a DNA microarray for detection of expressed equine classical MHC class I sequences in a defined population.

Ramsay JD, Leib SR, Orfe L, Call DR, Tallmadge RL, Fraser DG, Mealey RH.

Immunogenetics. 2010 Sep;62(9):633-9. doi: 10.1007/s00251-010-0463-y. Epub 2010 Aug 4.


Selection of a rare neutralization-resistant variant following passive transfer of convalescent immune plasma in equine infectious anemia virus-challenged SCID horses.

Taylor SD, Leib SR, Carpenter S, Mealey RH.

J Virol. 2010 Jul;84(13):6536-48. doi: 10.1128/JVI.00218-10. Epub 2010 Apr 14.


Identification of Rhodococcus equi lipids recognized by host cytotoxic T lymphocytes.

Harris SP, Fujiwara N, Mealey RH, Alperin DC, Naka T, Goda R, Hines SA.

Microbiology. 2010 Jun;156(Pt 6):1836-47. doi: 10.1099/mic.0.035915-0. Epub 2010 Mar 18.


Viral load and clinical disease enhancement associated with a lentivirus cytotoxic T lymphocyte vaccine regimen.

Mealey RH, Leib SR, Littke MH, Wagner B, Horohov DW, McGuire TC.

Vaccine. 2009 Apr 21;27(18):2453-68. doi: 10.1016/j.vaccine.2009.02.048. Epub 2009 Feb 24.


Development and characterization of an equine infectious anemia virus Env-pseudotyped reporter virus.

Tallmadge RL, Brindley MA, Salmans J, Mealey RH, Maury W, Carpenter S.

Clin Vaccine Immunol. 2008 Jul;15(7):1138-40. doi: 10.1128/CVI.00088-08. Epub 2008 Apr 30.


Experimental Rhodococcus equi and equine infectious anemia virus DNA vaccination in adult and neonatal horses: effect of IL-12, dose, and route.

Mealey RH, Stone DM, Hines MT, Alperin DC, Littke MH, Leib SR, Leach SE, Hines SA.

Vaccine. 2007 Oct 23;25(43):7582-97. Epub 2007 Aug 15.


Cloning and large-scale expansion of epitope-specific equine cytotoxic T lymphocytes using an anti-equine CD3 monoclonal antibody and human recombinant IL-2.

Mealey RH, Littke MH, Leib SR, Davis WC, McGuire TC.

Vet Immunol Immunopathol. 2007 Jul 15;118(1-2):121-8. Epub 2007 Apr 8.


Evaluation of high functional avidity CTL to Gag epitope clusters in EIAV carrier horses.

Chung C, Mealey RH, McGuire TC.

Virology. 2005 Nov 25;342(2):228-39. Epub 2005 Sep 1.

Supplemental Content

Loading ...
Support Center